Even when IVF is covered by insurance, high bills and hassles abound
About 1 in 5 women have trouble getting pregnant, and IVF has become a common path to parenthood for many. But even as demand grows, insurance coverage remains limited.
Delivering new life into the fertility market: How digital health is reinventing the path to parenthood
Through thoughtful consumer-centric design and application, these digital fertility solutions have the potential to smooth the path towards parenthood for countless couples and individuals around the world.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Silicon Valley startup Univfy is bringing machine learning to fertility treatments
The company uses machine learning-based analysis of clinical data to help fertility clinics provide personalized patient reports with success probabilities for potential IVF participants.
Who gets “custody” when a married couple has frozen embryos but then decides to divorce?
It's still a complicated issue legally if a partner in a marriage that has ended in divorce is able to use previously frozen, fertilized eggs without the other person's consent.
The genetics of infertility: Celmatix raises $5.5M for its precision medicine approach to IVF
New York startup Celmatix just raised $5.5 million for its predictive software that determines a woman's likelihood of infertility based on her genomics.
Wow of the Week: Britain shows support for genetically modified embryos to prevent disease
Talk about wow. Reports out of Britain this week suggest that it could soon become the first country to allow an in-vitro fertilization technique that uses genetic material from three people. The technique in question – referred to as three-parent in vitro fertilization – involves intervention in the fertilization process to remove defective mitochondrial DNA […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.